/Investor DB

BIOSPRING PARTNERS — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Labvivalabviva.cominSeries A · Jan 2025 · $25M✓ verified

Labviva is an AI-native procurement platform that unifies the life sciences supply chain, helping research organizations optimize procurement processes and reduce costs.

AI & Machine LearningBiotechEnterprise SoftwareSaaSCambridge, US

Siamak Baharloo(Executive Officer, Director)inCarlo(GM of Europe)inNick Premnath(SVP of Commercial Strategy)inAaron Miramontes(Executive Officer)Nicholas Rioux(Executive Officer, Director)in

BoardSarah Fay(Director)in

Co-investorsGlasswing VenturesVillage Global53 StationsB Capital GroupB4 CapitalMassVentures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.